During the past decade, Treatment and Diagnosis Center of Leukemia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Treatment and Diagnosis Center of Leukemia" are "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Treatment and Diagnosis Center of Leukemia" in a lesser frequency.

Most popular intervention types in "Treatment and Diagnosis Center of Leukemia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CAG regimen (Aclacinomycin, cytarabine, with/w/o G-CSF)" (1 trials), "Cytarabine" (1 trials), "Daunorubicin" (1 trials) and "low dose cytarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Treatment and Diagnosis Center of Leukemia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Treatment and Diagnosis Center of Leukemia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Treatment and Diagnosis Center of Leukemia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Treatment and Diagnosis Center of Leukemia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".